On Friday, a Craig-Hallum analyst increased the price target for Harrow Health (NASDAQ: NASDAQ:HROW) shares to $30.00, up from the previous $26.00, while maintaining a Buy rating on the stock. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback